Cerus

In our latest webinar, Dr. Allison P Wheeler from WACBD - Washington Center for Bleeding Disorders presents key findings from the PIPER Study, the largest Phase IV prospective study of platelet transfusion-associated pulmonary injury to-date.? ?? View the full webinar here: https://lnkd.in/gMmVPyhy? ?? #platelets #pathogeninactivation #bloodsafety #transfusionmedicine?#cerus ?

Centers for Disease Control and Prevention just published the latest results of the 2023 National Blood Collection and Utilization Survey (NBCUS) in which national trends in US blood availability are described (1). Findings include:? ? Responses from 96% of community-based blood centers and 85.7% of transfusing hospitals, the highest to date?? ? Stabilization in the blood supply with a return to pre-COVID-19 pandemic levels? ? Shift from whole-blood derived platelets in favor of apheresis platelets, the former of which have been associated with a higher risk of viral transfusion transmission?due to multiple donor exposure? ? More than half of the nation’s supply of apheresis platelets are pathogen reduced?? ?? Read more about the NBCUS (https://lnkd.in/gF_bycEc)? ?? #bloodavailability #patientsafety #transfusionmedicine #pathogenreduction??#cerus (1) McDavid K, et al. Transfusion. 2025 Mar 11. Epub ahead of print.?

?? Patient Safety Awareness Week | March 9–15, 2025 ?? Patient safety is at the heart of everything we do. During Patient Safety Awareness Week, we recognize the progress made in healthcare safety, and all the dedicated individuals behind that progress, including @ptsafetyexpert. We also acknowledge the urgent need to do more to ‘move the needle’ -- preventable harm remains a global public health challenge, impacting millions of lives each year. At Cerus, we are committed to advancing the blood transfusion safety by reducing the risk of transfusion-transmitted infections. A safer blood supply requires innovation, collaboration, and continued investment in technologies like pathogen reduction.? We all have a role to play in making healthcare safer. Join us in recognizing this week and advocating for solutions that put patient safety first.?? #PSAW25 #PatientSafety #BloodSafety #PathogenReduction #PathogenInactivation ?

Reflecting on 5 Years Since the COVID-19 Pandemic Declaration ? Five years ago today, the World Health Organization declared COVID-19 a global pandemic. This milestone marked the beginning of a profoundly challenging time that reshaped healthcare systems, economies, and our daily lives across the globe. As we reflect on the lessons learned and the resilience shown by communities everywhere, we also honor the healthcare workers, blood donors, researchers, and countless others who stepped up in extraordinary ways to protect lives and strengthen public health systems. The pandemic underscored the critical importance of safe and reliable blood supplies and highlighted the need for innovation in transfusion medicine. At Cerus, we remain committed to advancing technologies that support blood safety and pandemic preparedness. Learn more about our work here: https://www.cerus.com/? #COVID19Anniversary #PandemicPreparedness #BloodSafety #GlobalHealth?

Cerus is proud to be a sponsor for America’s Blood Centers’ (ABC) Annual Meeting to be held in Arlington, VA from March 10-12th. Dr. Nina Mufti, Sr. VP of Research and Development at Cerus, has been invited to present as part of ABC’s “New Products and Technology Showcase” session on March 11th, where she’ll discuss perspectives on protecting the blood supply with pathogen reduction. We look forward to seeing you there!? ? #ABC2025 #patientsafety #transfusionmedicine #pathogenreduction???

Today, Cerus announced receipt of CE mark for next-generation INTERCEPT Illumination Device (INT200). You can read the full press release here: https://ow.ly/wMNc50Vbfrj

March is American Red Cross Month ? This month, we honor the incredible volunteers and humanitarian work of the American Red Cross, who provide critical services across the globe—from disaster relief to emergency assistance, and so much more. Their efforts save lives, rebuild communities, and bring hope to those in need. At Cerus, we deeply respect the mission of the Red Cross and are proud to support their efforts, especially in the areas of blood donation and emergency care. Volunteers are the backbone of their work, and this month, we celebrate all the individuals who give their time, energy, and compassion to help others in times of crisis. Let’s take a moment to acknowledge the selflessness of Red Cross volunteers and find ways we can all contribute to making the world a better place. ?? Learn how you can volunteer or support the American Red Cross: redcross.org #RedCrossMonth #HelpCantWait #Volunteer #HumanitarianWork #RedCross #CommunitySupport?

The Cerus story is a unique one, addressing the need for blood safety and availability over 30+ years. With this history comes the need to communicate our mission to many different audiences. Learn more about how we’ve done this in Jessica Hanover's conversation with Kimberly Kraemer of life sciences agency Waterhouse Brands. https://lnkd.in/g2kPdHf4?

?? February 28 is Rare Disease Day ??? ?? Today, we shine a light on the millions of people worldwide living with rare diseases. While these conditions may be less common, the challenges faced by patients and families are immense—and the need for specialized care is crucial.? ?? At Cerus, we recognize the importance of safe and reliable blood products for patients with rare diseases. Many of these individuals depend on blood transfusions as part of their treatment. Our technology plays a vital role in ensuring that blood transfusions are as safe as possible for patients who rely on these critical therapies.? ?? On Rare Disease Day, we raise awareness and advocate for better care, better treatments, and a better future for those with rare diseases.? ? ?? Learn more about how you can support Rare Disease Day: www.rarediseaseday.org #RareDiseaseDay #PathogenReduction #BloodSafety #LifesavingDonations #RareDiseases #PatientCare? ?

Today, Cerus announced its Full-Year and Fourth Quarter 2024 Financial Results. To read the full earnings release, visit: https://ow.ly/8qUX50V3S5B